Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024

Rhea-AI Summary

Inspire Medical Systems, Inc. (NYSE: INSP) has announced it will release its third quarter 2024 financial results after the market closes on Monday, November 4, 2024. The company's management team will host a conference call at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

Investors can access the earnings call webcast through the Investor Relations page of Inspire's website or via a provided link. Those planning to ask questions during the call should register using a separate link. Registration is recommended at least 10 minutes before the call starts. A replay of the call will be available on the company's Investor Relations website approximately two hours after the event and will be archived for two weeks.

MINNEAPOLIS, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2024 after the close of trading on Monday, November 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q3 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Inspire's Q3 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. 

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

When will Inspire Medical Systems (INSP) release its Q3 2024 financial results?

Inspire Medical Systems (INSP) will release its third quarter 2024 financial results after the close of trading on Monday, November 4, 2024.

What time is Inspire Medical Systems' (INSP) Q3 2024 earnings call scheduled for?

Inspire Medical Systems' (INSP) Q3 2024 earnings call is scheduled for 5:00 p.m. Eastern Time on November 4, 2024.

How can investors access Inspire Medical Systems' (INSP) Q3 2024 earnings call?

Investors can access Inspire Medical Systems' (INSP) Q3 2024 earnings call via a webcast on the company's Investor Relations page or through a provided link. Those planning to ask questions should register using a separate link.

Will there be a replay available for Inspire Medical Systems' (INSP) Q3 2024 earnings call?

Yes, a replay of Inspire Medical Systems' (INSP) Q3 2024 earnings call will be available on the company's Investor Relations website approximately two hours after the event and will be archived for two weeks.